The recent retraction of a paper in Science Translational Medicine reporting “one of the biggest things to happen” in narcolepsy research has claimed a bystander: A letter that commented on the no-longer-landmark article.
The authors of the letter are with GlaxoSmithKline’s vaccine division. Here’s the new notice: Continue reading Downstream effects: Comment on retracted narcolepsy paper retracted
PLoS One has retracted a 2013 article on atherosclerosis in mice over concerns about the integrity of the data.
The paper, “The Effect of Soluble RAGE on Inhibition of Angiotensin II-Mediated Atherosclerosis in Apolipoprotein E Deficient Mice,” came from a group of researchers in South Korea.
It purported to show that: Continue reading Data questions prompt retraction of PLOS ONE cardiovascular paper
Here at Retraction Watch, we don’t believe in the expression “TMI.” But this case features a level of detail we’re not sure we’ve seen before.
Acta Radiologica has pulled a 2012 article on breast cancer imaging for being a duplicate publication — a sin the retraction notice takes great pains to point out.
The notice, written by journal editor Arnulf Skjennald, has the blow-by-blow feel of a police report: Continue reading Retraction, tell-all style, for breast cancer radiology paper
A group of liver researchers from the University of Pittsburgh has earned a pair of corrections in Hepatology for image problems.
The team was led by George K. Michalopoulos, chair of the department of pathology at the University of Pittsburgh Medical Center.
One article, “Excessive hepatomegaly of mice with hepatocyte-targeted elimination of integrin linked kinase following treatment with 1,4-bis [2-(3,5-dichaloropyridyloxy)] benzene,” appeared in January 2011. According to the notice: Continue reading Hepatology issues corrections in two papers from Pitt liver group
Last month, PubPeer announced that a scientist had threatened to sue the site for defamation. At the time, all PubPeer would say was that the “prospective plaintiff” is a US researcher” who was “aggrieved at the treatment his papers are getting on our site.”
Today, PubPeer revealed the that the prospective plaintiff was Fazlul Sarkar, a distinguished professor of pathology at Wayne State University in Detroit. Sarkar’s attorney, Nicholas Roumel, tells us that Sarkar had a job offer from the University of Mississippi, which rescinded it after seeing comments about his work on PubPeer.
We asked to see the letter rescinding the offer, but Roumel said he couldn’t send it because he and Sarkar are “in the process of making a claim against them.”
We also asked if there was an investigation into Sarkar’s work. Roumel told us:
As for any investigation, federal regulations make such things strictly confidential, so I can’t comment either way.
According to a post on PubPeer: Continue reading Scientist threatening to sue PubPeer claims he lost a job offer because of comments
A chemical engineering paper published in February has been retracted for data and authorship problems.
According to the retraction notice, the authors’ institutions investigated and found that not only was the data not reproducible, but “not all co-authors on the manuscript were aware of or agreed to the content and scientific conclusions in the article.”
Here’s the notice in the Journal of Chemical & Engineering Data for “Ionic Liquids as Promising Solvents for Biomass Derived Mannitol and Xylitol”: Continue reading Solvent paper dissolves under heat of institutional investigation
Karel Bezouška, a researcher who broke into a lab refrigerator to tamper with an investigation into his work, has nine retractions.
Here’s the retraction notice in Biochemistry for 2010’s “Cooperation between Subunits Is Essential for High-Affinity Binding of N-Acetyl-d-hexosamines to Dimeric Soluble and Dimeric Cellular Forms of Human CD69:” Continue reading Researcher who broke into lab up to nine retractions
A group of researchers from Egypt has lost their 2013 article on hepatitis C in the Journal of Immunoassay and Immunochemistry for fudging their figures.
The article was titled “In vitro neutralization of HCV by goat antibodies against peptides encompassing regions downstream of HVR-1 of E2 glycoprotein.” According to the abstract: Continue reading Image manipulation forces retraction of hepatitis C paper
As we’ve pointed out before, economics and business journals have few retractions compared with the other academic literature. Opinions vary on why this is, but the fact that only a few journals have plagiarism policies can’t help.
Research Papers in Economics, or RePEc, an organization that maintains a database of economics papers, however, thoroughly investigates accusations of misconduct. A RePEc report, which indicated that the plagiarists were polite enough to cite the original paper, was used in the notice as evidence for a retraction in Economic Modelling.
Here’s the notice for “Retraction notice to “Analysis of nonlinear duopoly game with heterogeneous players”: Continue reading Economics paper retracted for plagiarism after citing its twin
The Office of Research Integrity (ORI) has ruled in a case we’ve been following for nearly two years — and which seems to have been launched after Retraction Watch readers took a careful look at figures from what appeared to be an unrelated case.
Takao Takahashi and Makato Suzuki, both former postdocs at a cancer research center at UT-Southwestern, both “knowingly, intentionally, and recklessly falsified data” in a total of 10 papers, according to the ORI. Takahashi, now at Gifu University in Japan, was responsible for fakery in four papers, while Suzuki, now at Kumamoto University Hospital, also in Japan, falsified data in six.
We reported on the retraction of the four Takahashi papers, and one of the Suzuki papers, in November 2012. At that time, Adi Gazdar, the head of the lab where the researchers worked, told us that
Continue reading Former UT-Southwestern cancer researchers faked data in 10 papers: ORI